Tocqueville Asset Management L.P. Buys New Shares in CVS Health Corporation $CVS

Tocqueville Asset Management L.P. purchased a new position in CVS Health Corporation (NYSE:CVS) in the second quarter, Holdings Channel.com reports. The firm purchased 301,191 shares of the pharmacy operator’s stock, valued at approximately $31,158,000.

Other institutional investors and hedge funds have also bought and sold shares of the company. Addison Advisors LLC purchased a new position in shares of CVS Health in the second quarter valued at about $41,000. Mmbg Investment Advisors CO. purchased a new stake in shares of CVS Health during the second quarter worth about $722,000. West Family Investments Inc. purchased a new stake in shares of CVS Health during the second quarter worth about $176,000. NewEdge Wealth LLC bought a new stake in CVS Health during the 2nd quarter valued at approximately $2,166,000. Finally, Empirical Asset Management LLC purchased a new position in CVS Health in the 2nd quarter worth approximately $566,000. 80.66% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. Morgan Stanley increased their price objective on shares of CVS Health from $106.00 to $111.00 and gave the company an “overweight” rating in a report on Thursday, June 4th. Wells Fargo & Company boosted their target price on shares of CVS Health from $103.00 to $123.00 and gave the stock an “overweight” rating in a report on Monday, July 13th. Cantor Fitzgerald upped their target price on shares of CVS Health from $100.00 to $110.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 7th. Bank of America lifted their price target on shares of CVS Health from $100.00 to $110.00 and gave the company a “buy” rating in a report on Monday, June 22nd. Finally, Royal Bank Of Canada boosted their price target on shares of CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a research note on Thursday, July 9th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $107.17.

CVS Health Trading Down 1.4%

Shares of CVS stock opened at $93.58 on Thursday. The company has a market cap of $119.68 billion, a PE ratio of 24.76, a price-to-earnings-growth ratio of 0.91 and a beta of 0.61. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The stock’s 50 day simple moving average is $102.32 and its two-hundred day simple moving average is $88.69. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, topping analysts’ consensus estimates of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to analysts’ expectations of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company’s quarterly revenue was up 7.3% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. Research analysts predict that CVS Health Corporation will post 8.02 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, July 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. CVS Health’s payout ratio is 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.